Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Pramodini MedicareNSE:PRAMODINI -2.01%19 Market Cap is ₹2,530.8 Mil as of Aug. 31, 2026. GuruFocus rates NSE:PRAMODINI with a GF Score™ of 19/100. The stock has 1 warning sign investors should review. Among 693 Healthcare Providers & Services companies, Pramodini Medicare ranks worse than 72.29% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Pramodini Medicare's share price for the quarter that ended in Mar. 2026 was ₹0. Pramodini Medicare's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 22.0 Mil. Therefore, Pramodini Medicare's market cap for the quarter that ended in Mar. 2026 was ₹0.0 Mil.
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Pramodini Medicare's Enterprise Value for Today is ₹2,644.9 Mil.
Pramodini Medicare (NSE:PRAMODINI) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Pramodini Medicare Market Cap Related Terms
Pramodini Medicare Market Cap Historical Data
* Premium members only.
The historical data trend for Pramodini Medicare's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pramodini Medicare Market Cap Chart
Pramodini Medicare Annual Data
Trend
Mar23
Mar24
Mar25
Mar26
Market Cap
0.00
0.00
0.00
0.00
Pramodini Medicare Quarterly Data
Mar23
Mar24
Mar25
Dec25
Mar26
Market Cap
0.00
0.00
0.00
0.00
0.00
NSE:PRAMODINI vs HCA, THC, EHC: Market Cap Comparison
For the Medical Care Facilities subindustry, Pramodini Medicare's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pramodini Medicare Market Cap vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Pramodini Medicare's Market Cap distribution charts can be found below:
* The bar in red indicates where Pramodini Medicare's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Pramodini Medicare's Market Cap for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pramodini Medicare (NSE:PRAMODINI) has a Market Cap of ₹2,530.8 Mil as of Aug. 31, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Pramodini Medicare and its competitors. According to the industry distribution chart, Pramodini Medicare ranks #501 out of 693 companies in the Healthcare Providers & Services industry, placing it in the top 72.3%.
Is Pramodini Medicare's Market Cap too high?
Pramodini Medicare's current Market Cap is ₹2,530.8 Mil. Based on the distribution chart, Pramodini Medicare ranks #501 out of 693 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Pramodini Medicare has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Pramodini Medicare's Market Cap compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Pramodini Medicare ranks #501 out of 693 companies for Market Cap. This places Pramodini Medicare in the lower half of its industry. The industry median Market Cap is 112.22. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Healthcare Providers & Services company?
The median Market Cap among Healthcare Providers & Services companies is 112.22, based on 693 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Pramodini Medicare and its competitors. For the Healthcare Providers & Services industry, the median Market Cap is 112.22 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pramodini Medicare's current Market Cap is ₹2,530.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pramodini Medicare stock overvalued right now?
Pramodini Medicare (NSE:PRAMODINI) has a current Market Cap of ₹2,530.8 Mil. The current Market Cap is ₹2,530.8 Mil. Pramodini Medicare's overall GF Score™ is 19/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Pramodini Medicare (NSE:PRAMODINI), the current Market Cap is ₹2,530.8 Mil as of Aug. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Pramodini Medicare Ltd is a diagnostic service provider in India. It provides a range of technology-enabled diagnostic services such as radiology, clinical laboratory and nuclear medicine service to public hospitals, private hospitals, certain PSU (Public Sector Undertaking) of Government of India and medical colleges across tier I, tier II and tier III cities throughout India. The company also provide teleradiology services, which functions on a 24*7 basis throughout the year. It provides healthcare services for core testing, patients diagnosis, disease prevention and monitoring of various health conditions. Its services includes both routine and specialized tests, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of diseases.
19GF Score
Get the complete analysis for NSE:PRAMODINI
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:PRAMODINI has been successfully added to your 
